A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Healthy
Interventions: BIOLOGICAL: ALT02|BIOLOGICAL: EU-licensed Herceptin|BIOLOGICAL: US-licensed Herceptin
Sponsor: Alteogen, Inc.
Collaborators: Cristália Produtos Químicos Farmacêuticos Ltda.